These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15786541)

  • 1. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
    Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
    World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer.
    Chang PH; Pan YP; Fan CW; Tseng WK; Huang JS; Wu TH; Chou WC; Wang CH; Yeh KY
    Cancer Med; 2016 Mar; 5(3):426-33. PubMed ID: 26799163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator.
    Chung YC; Chang YF
    Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):369-73. PubMed ID: 12655256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
    Li ZP; Han JQ; Meng XW; Yang YF
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
    Chung YC; Chang YF
    J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.
    Thomsen M; Kersten C; Sorbye H; Skovlund E; Glimelius B; Pfeiffer P; Johansen JS; Kure EH; Ikdahl T; Tveit KM; Christoffersen T; Guren TK
    Oncotarget; 2016 Nov; 7(46):75013-75022. PubMed ID: 27738330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
    Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
    Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
    Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
    Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
    PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer.
    Nozoe T; Matsumata T; Kitamura M; Sugimachi K
    Am J Surg; 1998 Oct; 176(4):335-8. PubMed ID: 9817250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.
    Kiblawi R; Holowatyj AN; Gigic B; Brezina S; Geijsen AJMR; Ose J; Lin T; Hardikar S; Himbert C; Warby CA; Böhm J; Bours MJL; van Duijnhoven FJB; Gumpenberger T; Kok DE; Koole JL; van Roekel EH; Schrotz-King P; Ulvik A; Gsur A; Habermann N; Weijenberg MP; Ueland PM; Schneider M; Ulrich A; Ulrich CM; Playdon M
    Br J Nutr; 2020 May; 123(10):1187-1200. PubMed ID: 32019627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
    Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
    Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
    Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
    Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
    PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Wereszczyńska-Siemiatkowska U; Kedra B; Lukaszewicz M; Baniukiewicz A; Szmitkowski M
    Clin Chem Lab Med; 2008; 46(10):1423-8. PubMed ID: 18844497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients.
    Kamińska J; Kowalska MM; Nowacki MP; Chwaliński MG; Rysińska A; Fuksiewicz M
    Pathol Oncol Res; 2000; 6(1):38-41. PubMed ID: 10749586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
    Elessawi DF; Alkady MM; Ibrahim IM
    Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.